Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection

Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection

<b>Introduction:</b> Lung cancer is one of the most diagnosed malignancies with increasing incidence worldwide. Immunotherapy is the main oncological treatment for advanced non-small cell lung cancer (NSCLC), for which the discovery of new efficient biomarkers is crucial. Scientific evid...

Full description

Bibliographic Details
Main Authors: Kristina Krpina, Martina Mavrinac, Miroslav Samarzija, Ena Tolic, Dora Darapi, Lara Baticic
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Clinical Medicine
Subjects:
chemotherapy
immunotherapy
lung immune prognostic index
non-small-cell lung cancer
COVID-19
Online Access:https://www.mdpi.com/2077-0383/11/22/6695

Internet

https://www.mdpi.com/2077-0383/11/22/6695

Similar Items